SINOVAC Biotech Ltd. ("SINOVAC") is a China-based leading biopharmaceutical company that focuses on the research, development, production, and commercialization of vaccines that protect against human infectious diseases.
More2023/12/20
The company's launch ceremony was led by Sinovac's CEO and Chairman, Mr. Weidong Yin, alongside Bogotá's Mayor, Claudia López. December 18, 2023, Bogotá, Colombia – Sinovac Biotech Ltd. (
On December 12, 2023, Chilean President Gabriel Boric met with a delegation led by Mr. Yin Weidong, Chairman, President, and CEO of SINOVAC, at the Presidential Palace La Moneda in Chile. Both sides h
2023/12/12
On December 5, 2023, Mayor of Bogotá Claudia López and Colombian Ambassador to China Sergio Caffaratti, visited Sinovac Biotech Ltd. ("SINOVAC" or the "Company") in Beijing to meet
2023/12/07
Ambassador Musa and SINOVAC Chairman Explore Continued Investment and Cooperation On November 8, Dr. Ismail Hak Musa, Turkish Ambassador to China, visited Sinovac Biotech Ltd. ("SINOVAC" or
2023/11/09
SINOVAC has undertaken nearly 60 national and regional science and technology
R&D projects; received two State Scientific and Technology Progress Awards
and three national-level institutional technology awards; and published more than
140 SCI papers, many of which were published in top academic journals including
New England Journal of Medicine, The Lancet, Science and Nature, etc.
SINOVAC approved products include: COVID-19 Vaccine (Vero Cell), Inactivated - CoronaVac®, Enterovirus Type 71 Vaccine (Vero cell), Inactivated - Inlive®, Hepatitis A Vaccine (Human Diploid Cell) Inactivated - Healive®, Influenza Vaccine (Split Virion), Inactivated - Anflu®, 23-valent Pneumococcal Polysaccharide Vaccine, Varicella Vaccine(Live), Mumps Vaccine(Live), etc.